INDEPENDENT DRUG SAFETY BD
Summary
Urges the President of the United States, the Congress of the United States, and the U.S. Food and Drug Administration to establish an independent board of drug safety and a public database of all clinical trial data to ensure that the safety and efficacy of drugs that are sent to market and that stay on the market are subject to the scrutiny of the public and doctors and researchers who have no financial ties to the drug industry.
Bill status
passed
3 of 5 stages cleared
Introduction
Feb 2005
Committee Review
Mar 2005
Senate Passage
Apr 2005
House Passage
Governor
Introduced Feb 2, 2005
Last action Apr 21, 2005
Floor votes
How they voted
This bill passed the Senate. No roll call record of that vote is available.
Full legislative history
Actions timeline
Total actions
8
Key actions
1
Committee
3
Apr 21, 2005
Senate · Passed
Resolution Adopted
Mar 17, 2005
Senate · Reported by committee
Be Adopted Health & Human Services; 010-000-000
Feb 17, 2005
Senate · Referred to committee
Assigned to Health & Human Services
Feb 2, 2005
Senate · Referred to committee
Referred to Rules
0 primary · 1 co-sponsor
Sponsors
Role
Legislator
Party
State
District
Co
Iris Y. Martinez
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SR 35
Scope: IL
Hi! I can help you understand SR 35. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline